AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,700,730 | +786.2% | 515,099 | +388.4% | 0.00% | – |
| Q3 2022 | $869,000 | +187.7% | 105,475 | +129.1% | 0.00% | – |
| Q2 2022 | $302,000 | +22.8% | 46,043 | +4.3% | 0.00% | – |
| Q1 2022 | $246,000 | +62.9% | 44,140 | +37.6% | 0.00% | – |
| Q4 2021 | $151,000 | -66.1% | 32,088 | -55.4% | 0.00% | – |
| Q3 2021 | $445,000 | -6.1% | 71,916 | +0.1% | 0.00% | – |
| Q2 2021 | $474,000 | -56.2% | 71,855 | -51.5% | 0.00% | – |
| Q1 2021 | $1,083,000 | +825.6% | 148,032 | +630.4% | 0.00% | – |
| Q4 2020 | $117,000 | +11.4% | 20,266 | +15.0% | 0.00% | – |
| Q3 2020 | $105,000 | -91.7% | 17,619 | -92.8% | 0.00% | – |
| Q2 2020 | $1,259,000 | +2827.9% | 244,411 | +1935.4% | 0.00% | – |
| Q1 2020 | $43,000 | – | 12,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,739,255 | $22,544,000 | 7.01% |
| Worth Venture Partners, LLC | 685,026 | $5,638,000 | 3.45% |
| NEA Management Company, LLC | 3,952,957 | $32,533,000 | 1.62% |
| Birchview Capital, LP | 140,000 | $1,152,000 | 0.81% |
| Rubric Capital Management LP | 1,664,667 | $13,700,000 | 0.69% |
| EAM Investors, LLC | 380,691 | $3,133,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 368,520 | $3,033,000 | 0.52% |
| X-Square Capital, LLC | 92,283 | $759,000 | 0.48% |
| EAM Global Investors LLC | 211,759 | $1,743,000 | 0.46% |
| J. Goldman & Co LP | 656,161 | $5,400,000 | 0.26% |